Pramine and Hytrin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pramine (imipramine hydrochloride) and Hytrin (terazosin hydrochloride). Common drug interactions include alanine aminotransferase increased among females and red blood cell count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Pramine and Hytrin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Pramine?

Pramine has active ingredients of imipramine hydrochloride. eHealthMe is studying from 7,461 Pramine users. Check the latest studies of Pramine.

What is Hytrin?

Hytrin has active ingredients of terazosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 7,501 Hytrin users. Check the latest studies of Hytrin.

On Aug, 03, 2026

19 people who take Pramine and Hytrin together, and have interactions are studied.

What are the common drug interactions of Pramine and Hytrin, by gender? *:

female:

Alanine aminotransferase increased
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Aspartate aminotransferase increased
Back pain
Blood alkaline phosphatase nos increased
Blood bilirubin increased
Clamminess (moist, sticky, and cold to the touch)
Faeces discoloured
Gamma-glutamyltransferase increased
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)

male:

Red blood cell count decreased
Dry skin
Skin discolouration (change of skin colour)
Skin induration (an abnormally hard spot or area on the skin)
Abdominal distension
Dyspnoea exertional (breathlessness or shortness of breath)
Nightmare (unpleasant dream)
White blood cell count decreased
Oedema lower limb (fluid collection in tissue of lower leg)
Platelet count decreased

What are the common drug interactions of Pramine and Hytrin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Hyperammonaemia
Lethargy (tiredness)
Weight decreased

50-59:

Abdominal pain
Alanine aminotransferase increased
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Aspartate aminotransferase increased
Back pain
Blood alkaline phosphatase nos increased
Blood bilirubin increased
Clamminess (moist, sticky, and cold to the touch)
Colitis pseudomembranous (antibiotic-associated diarrhoea)
Faeces discoloured

60+:

Red blood cell count decreased
Dry skin
Skin discolouration (change of skin colour)
Skin induration (an abnormally hard spot or area on the skin)
Abdominal distension
Dyspnoea exertional (breathlessness or shortness of breath)
Nightmare (unpleasant dream)
White blood cell count decreased
Oedema lower limb (fluid collection in tissue of lower leg)
Platelet count decreased

What are the existing conditions these people have? *

Sleep Apnea Syndrome: 4 people, 21.05%
Nuclear Magnetic Resonance Imaging Brain: 4 people, 21.05%
Headache (pain in head): 4 people, 21.05%
Brain Stem Syndrome: 4 people, 21.05%

* Approximation only. Some reports may have incomplete information.

Do you take Pramine and Hytrin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously